Top Banner
SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based Medicine Unit FMUI – CMH, Jakarta
48

SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

Apr 01, 2015

Download

Documents

Reyna Clarkin
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

(”Bringing research evidenceinto practice”)

Evidence-Based Medicine

Sudigdo Sastroasmoro

Clinical Epidemiology and Evidence-based Medicine Unit

FMUI – CMH, Jakarta

Page 2: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

5-day workshop3-day workshop2-day workshop

Page 3: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Evidence-based Medicine

Opinion-based medicineExperience-based medicinePower-based medicineHope-based medicineLogic-based medicineErratic-based medicine

versus

Page 4: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Dr. Benjamin Spock:Baby and Child Care

“I think it is preferable to accustom a baby to sleeping on his stomach from the start of he is willing. He may change later when he learns to turn over”.

Later evidence indicates that prone position is aan significant risk factor for SIDS (sudden infant death syndrome)

Page 5: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Evidence-based Medicine

Medicine-based evidencePragmatic researchOutcome research

Related with morbidity, mortality, quality

of life

Page 6: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Value = Quality

Cost

MorbidityMortality

QoL

PatientSatisfaction

Health Status

Page 7: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Diagnosis

Patient with complaintHistoryPhysicalSimple testSpecific test: If the test (+) what is the probability that the patient has the disease? Yes or no answer Predictive value is the most important

The spectrum of the presentations must resemble that in practice

Page 8: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

TreatmentPatient with certain diagnosis: best treatment?Is drug X more effective than Y?Focus on the clinical outcome, rather than its explanation (biomolecular markers, etc)Yes or no outcome most usefulNot in studies with “idealized” subjects Px with DM are frequently have

hypercholesterolemia, obese, hypertension, etc

Page 9: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Prognosis

Usually in cohort studiesTo inform about the fate of the patient Absolute risk is more important than relative risk Absolute: Your risk of having second stroke in

1 year is 30% Relative: Your risk of having second stroke in

1 year is 2 times than in non-smokers (RR = 2)

Page 10: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Fletcher & Fletcher: CE = The application ofepidemiologic principles in problems

encountered in clinical medicineSackett et al: CE = The basic science for clinical medicineMuch resistance by expertsEBM: In principle – no one disagreeAll major medical journals have adopted EBMCenters for EBM all over the world

EBM & Clinical Epidemiology

Page 11: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Previous practice:

6 yrs medical

education

40-50 yrsmedical practice

Problems with patients:

Dx, Rx, Px

Consultants, colleaguesTextbooksHandbooks

Lecture notesClinical

guidelinesCME, seminars,

etcJournals

Usu. see only Results section,

or even worse, Abstract section

Page 12: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Trust meIn my experience ….LogicallyTextbook, handbook, capita selecta

Page 13: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

The results….“Opinion-based medicine”

Steroid inj. in prematures to prevent RDSRoutine episiotomyRoutine circumcisionAntibiotics for flu-like syndromeUse of immunomodulators“Skin test” before antibiotic injectionRoutine chest X-ray for pre-op preparationCT scan after minor head traumaetc ……

Page 14: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

What is Evidence-based Medicine?

“The conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”

“Pemanfaatan bukti mutakhir yang sahih dalam tata laksana pasien”

Integration of (1) physician’s competence (2) valid evidence from studies (3) patient’s preference

Page 15: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Pros : “New paradigm in medicine” “Extraordinary innovations,

only 2nd to Human Genome Project” Cons : New version of an old song ‘Fair’ : Nothing wrong with EBM, but:

• Be careful in searching evidence• Meta-analyses, clinical trials, and all study results should be critically appraised

Keyword for EBM: Methodological skill to judge the validity of study reports (Re. Andersen B:

Methodo-logical errors in medical research, 1989)

Page 16: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Y= a + b 1x 1

+ b 2X 2

+ b 3X 3

+ ……. + b ix i

εφlnΣδψ 2

$ 6,000

Yesss!!!

Page 17: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Page 18: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Dean, Harvard Medical School to students:

“We believe that 50% of what we are teaching to you now will prove to be false 5 years later; the problem is that we do not know which 50%”

Page 19: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

WHY EBM?1 Information overload 2 Keeping current with literature3 Our clinical performance deteriorates

with time (“the slippery slope”)4 Traditional CME does not improve

clinical performance

5 EBM encourages self directed learning process which should overcome the above shortages

Page 20: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Years after graduation

Relative% ofremainingknowledge

2 4 6 8 10 12

$100%

THE SLIPPERY SLOPE

Page 21: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Our textbooks are out-of-date

Fail to recommend Rx up to ten years after it’s been shown to be efficacious.Continue to recommend therapy up to ten years after it’s been shown to be useless.

Page 22: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

1. Formulate clinical problems in answerable questions

2. Search the best evidence: use internet or other on-line database for current evidence

3. Critically appraise the evidence for Validity (was the study valid?) Importance (were the results clinically

important?) Applicability (could we apply to our patient?)

4. Apply the evidence to patient5. Evaluate our performance

Steps in EBM practice

VIA

Page 23: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Diagnosis(Determination of disease or problem)

Treatment(Intervention necessary to help the patient)

Prognosis(Prediction of the outcome of the disease)

Main area

Page 24: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

(I)Formulating clinical questions

Page 25: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

A 2-year old boy presented with 6-day high fever, conjunctival injection without secretion, skin rash> blood test shows leukocytosis, high ESR, CRP +++. He was suspected to have Kawasaki disease. The pediatrician is aware of the use of immunoglobulin to prevent coronary involvement, but uncertain about the dosage or recent developments.

Page 26: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Medical students:(Background question)

What is Kawasaki disease? What is the etiology?How it is diagnosed?What is the treatment of choice?Complications?

Page 27: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

House officers(Foreground question)

In a child with KD, would immunoglobulin treatment, compared with no immunoglobulin, reduce the chance to develop coronary complication?

Page 28: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Foregroundquestions

Backgroundquestions

Experience with condition

Page 29: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

In women with history of eclampsia, would administration of low-dose aspirin during pregnancy prevent eclampsia? (Prevention)

Other examples

In young women with solitary thyroid nodule, can USG, compared with biopsy, differentiate between benign from malignant? (Diagnosis)

In women systemic lupus erythematosus, is history of congestive heart failure, compared with no heart failure, worsen the prognosis? (Prognosis)

Page 30: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Four elements of good clinical

question: PICOThe Patient or ProblemThe Intervention / IndexComparative intervention (if relevant)The Outcome

Page 31: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Four elements of a well constructed clinical

question: PICO

P I C O

The maininterventionconsidered

The alternativeto compare

with theintervention

Outcomeexpected from this

intervention?

Descriptionof patient

or problem

B e b r i e f a n d s p e c i f i c

Page 32: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Do all clinical questions contain 4 elements of

PICO?NoThe C implies in the question - PIO

Does temulawak increase appetite in undernourished children?

Asking prevalence – POWhat is the prevalence of abnormal gene XYZ in patients with -thalassemia?

Page 33: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Relevance: Type of Evidence

POE: Patient-oriented evidence mortality, morbidity, quality of life

DOE: Disease-oriented evidencepathophysiology, pharmacology, etiology

Page 34: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

POEM

Patient-OrientedEvidence

Page 35: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Comparing DOES and POEMs

Prostatescreening

PSA screeningdetects prostate

Ca. early

? whether PSAscreening mortality

DOE exists, butPOEM unknown

AntiarrhythmicTherapy

Antihypertens.Therapy

Drug A PVCOn ECG

Drug X BP Drug X mortality

Drug A > mortality

DOE & POEMcontradicts

POEM agreesWith DOE

Example DOE POEM Comment

Page 36: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

IISearching the evidence

Page 37: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

IIIAppraising the evidence:

VIA

Page 38: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Validity: In Methods section:design, sample, sample size, eligibility criteria (inclusion, exclusion), sampling method, randomization method, intervention, measurements, methods of analysis, etc

Importance: In Results sectioncharacteristics of subjects, drop out, analysis, p value, confidence intervals, etc

Applicability: In Discussion section + our patient’s characteristics, local setting

VIA

Page 39: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Were the subjects randomized?

Were all subjects received similar treatment?

Were all relevant outcomes considered?

Were all subjects randomized included in the analysis?

Calculate CER, EER, RRR, ARR, and NNT

Were study subjects similar to our patients in terms of prognostic factors?

Example: Critical appraisal for therapy

Page 40: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Hierarchy of evidence

Meta-analysis of RCT

Large RCT

Small RCT

Non-Randomized trials

Observational studies

Case series / reports

Anecdotes, expert, consensus

Level 1

Level 2

Level 3

Level 4

A

B

C

RecWeight ofScientific Scrutiny

For complete description see www.cebm.net

Page 41: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Implementation of EBM practice:

How to get started 1. Teaching EBM in medical schools / PPDS

• Easier than to change the already existing attitude• Most important • May be included in formal curricula or integrated in existing activities: ward rounds, on calls, case presentations, group discussions, journal clubs, etc

2. Workshop for teaching staff 3. Workshop for practitioners, incl. nurses

Page 42: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Resistance to EBM teaching & learning

• Rudimentary skill in critical appraisal / methodological skill• Limited resources, esp. time factor• Lack of high quality evidence• Skepticism toward evidence-based practice• ‘Happy’ with current practice

Page 43: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Physician’s competence

Valid evidencePatient’s values

Page 44: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

TheEBMCycle

PatientWith problem

FormulateIn answerable

question

Search theevidence

AppraiseThe

evidence

ApplyThe

evidence

Page 45: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Criticism to EBMEBM makes expensive medical careEBM cannot be implemented in developing countriesEBM is costly and time consumingEBM ignore pathophysiology & reasoningEBM ignore experience and clinical judgmentEB-guidelines etc interfere with professional autonomy

Page 46: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Advantages of EBMEncourages reading habitImproves methodological skill (and willingness to do research?!)Encourages rational & up to date management of patientsReduces intuition & judgment in clinical practice, but not eliminates themConsistent with ethical and medico-legal aspects of patient management

Page 47: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

End result

Self directed, life-long learning attitude

for high quality patient care

Page 48: SS/EBM/IKA-UDIP-2010 (”Bringing research evidence into practice”) Evidence-Based Medicine Sudigdo Sastroasmoro Clinical Epidemiology and Evidence-based.

SS/EBM/IKA-UDIP-2010

Conclusion

EBM is nothing more than aframework of systematic use ofcurrent valid study results relevant to our patient